Cost-effectiveness analysis of a large jail-based methadone maintenance treatment continuation program in New Mexico

被引:6
|
作者
Horn, Brady P. [1 ,2 ]
Li, Xiaoxue [1 ]
McCrady, Barbara [2 ,3 ]
Guerin, Paul [4 ]
French, Michael T. [5 ]
机构
[1] Univ New Mexico, Dept Econ, MSC 05 3060,1 Univ New Mexico, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Ctr Alcoholism Subst Abuse & Addict CASAA, 2650 Yale SE MSC11-6280, Albuquerque, NM 87106 USA
[3] Univ New Mexico, Dept Psychol, MSC 05 3060,1 Univ New Mexico, Albuquerque, NM 87131 USA
[4] Univ New Mexico, Inst Social Res, 1915 Las Lomas, Albuquerque, NM 87131 USA
[5] Univ Miami, Miami Herbert Business Sch, Dept Hlth Management & Policy, Coral Gables, FL 33124 USA
关键词
Opioid use disorder; Methadone maintenance; Cost-effectiveness analysis; Jail; Recidivism; SUBSTANCE-ABUSE TREATMENT; ECONOMIC-EVALUATION; DRUG-ABUSE; PRISON; ADDICTION; COMMUNITY; COURT;
D O I
10.1016/j.jsat.2020.108042
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The U.S. has the second-highest incarceration rate in the world and spends more than $80 billion annually to house inmates. The clinical research literature suggests that methadone maintenance treatment (MMT) is an effective method to treat opioid use disorders (OUD) and that jails are a potentially valuable environment to implement MMT. Currently, jail-based MMT is rarely implemented in practice, due in part to resource limitations and other economic considerations. The primary goal of this study was to perform a cost-effectiveness analysis (CEA) of jail-based MMT using data from a unique MMT continuation program located in a large urban jail in New Mexico. Recidivism data were collected for a three-year period both before and after incarceration, and quasi-control groups were constructed from both substance-using and general populations within the jail. Base models show that inmates enrolled in jail-based MMT exhibited significantly fewer days of incarceration due to recidivism (29.33) than a group of inmates with OUDs who did not receive MMT. Economic estimates indicate that it cost significantly less ($23.49) to reduce an incarcerated day using jail-based MMT than incarceration per se ($116.49). To mitigate potential sample selection bias, we used both propensity-score-matching and difference-in-differences estimators, which provided comparable estimates when using the OUD non-MMT comparison group. Difference-in-differences models find that, on average, MMT reduced recidivism by 24.80 days and it cost $27.78 to reduce an incarcerated day using jail-based MMT. Assuming a willingness to pay threshold of the break-even cost of reducing one incarcerated day, we estimate a 93.3% probability that this MMT program is cost-effective. Results were not as strong or consistent when using other comparison groups (e.g., alcohol-detoxified and general-population inmates). Overall, results suggest that it costs substantially less to provide jail-based MMT than incarceration alone. Jail administrators and policymakers should consider incorporating MMT in other jail systems and settings.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] A cost-effectiveness analysis model for treatment of chronic schizophrenia in Mexico
    Mould, J
    Contreras-Hernandez, I
    Verduzco, W
    Garduño-Espinosa, J
    VALUE IN HEALTH, 2006, 9 (03) : A67 - A67
  • [22] COST-EFFECTIVENESS ANALYSIS OF APIXABAN IN THE TREATMENT OF ATRIAL FIBRILLATION IN MEXICO
    Galindo-Suarez, R. M.
    Davila-Veites, A.
    Olguin-Sanchez, J. F.
    Haddad, A.
    del Angel-Martinez, J.
    Mucino-Ortega, E.
    VALUE IN HEALTH, 2013, 16 (07) : A524 - A524
  • [23] COST-EFFECTIVENESS ANALYSIS OF AMFEPRAMONE (DIETHYLPROPION) FOR THE OBESITY TREATMENT IN MEXICO
    Soto Molina, H.
    Diaz Martinez, J. P.
    Escobar Juarez, Y.
    Fernandez del Valle, C.
    VALUE IN HEALTH, 2014, 17 (07) : A531 - A532
  • [24] COST-EFFECTIVENESS ANALYSIS OF LEFLUNOMIDE AS A TREATMENT FOR RHEUMATOID ARTHRITIS IN MEXICO
    Carlos-Rivera, F.
    Aguirre-Granados, A.
    Manterola, S. O. M. C.
    VALUE IN HEALTH, 2008, 11 (06) : A537 - A537
  • [25] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN MEXICO
    Vargas-Valencia, J.
    Sotelo-Guzman, M.
    Mould-Quevedo, J. F.
    Mucino-Ortega, E.
    Galindo-Suarez, R. M.
    VALUE IN HEALTH, 2011, 14 (03) : A127 - A127
  • [26] COST-EFFECTIVENESS OF RIFAMPICIN-BASED CONTINUATION PHASE OF TUBERCULOSIS TREATMENT IN UGANDA
    Kuznik, A.
    Hermans, S.
    Castelnuovo, B.
    Auerbach, B.
    Ssewankambo, F.
    Sempa, J.
    Ssennono, M.
    Lamorde, M.
    Semeere, A.
    Manabe, Y. C.
    VALUE IN HEALTH, 2011, 14 (07) : A274 - A274
  • [27] A TREATMENT PROGRAM FOR FAILURE-TO-THRIVE - A COST-EFFECTIVENESS ANALYSIS
    KARNISKI, W
    VANBUREN, L
    CUPOLI, JM
    CHILD ABUSE & NEGLECT, 1986, 10 (04) : 471 - 478
  • [28] Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence
    Jackson, Heide
    Mandell, Kara
    Johnson, Kimberly
    Chatterjee, Debanjana
    Vanness, David J.
    SUBSTANCE ABUSE, 2015, 36 (02) : 226 - 231
  • [29] Cost-effectiveness of Methadone Maintenance Treatment in Prevention of HIV Among Drug Users in Shiraz, South of Iran
    Keshtkaran, Ali
    Mirahmadizadeh, Alireza
    Heidari, Alireza
    Javanbakht, Mehdi
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (01)
  • [30] A COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT FOR THE TREATMENT OF MODERATE AND SEVERE PSORIASIS IN MEXICO
    Vargas-Valencia, J.
    Sotelo-Guzman, M.
    Mould-Quevedo, J. F.
    Mucino-Ortega, E.
    Galindo-Suarez, R. M.
    VALUE IN HEALTH, 2011, 14 (03) : A55 - A55